# EDGAR Filing Document

**Accession Number:** 0001096752
**File Stem:** 0001096752-23-000008
**Filing Date:** 2023-2
**Character Count:** 30513
**Document Hash:** aaf845ada23db2c308edb9b0ca8053de
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001096752-23-000008.hdr.sgml**: 20230227

**ACCESSION NUMBER**: 0001096752-23-000008

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 4

**REFERENCES 429**: 333-236414

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230227

**EFFECTIVENESS DATE**: 20230224

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EDGEWELL PERSONAL CARE Co
- **CENTRAL INDEX KEY:** 0001096752
- **STANDARD INDUSTRIAL CLASSIFICATION:** PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
- **IRS NUMBER:** 431863181
- **STATE OF INCORPORATION:** MO
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-270027
- **FILM NUMBER:** 23669913

**BUSINESS ADDRESS:**
- **STREET 1:** 6 RESEARCH DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484
- **BUSINESS PHONE:** 203-944-5500

**MAIL ADDRESS:**
- **STREET 1:** 6 RESEARCH DRIVE
- **CITY:** SHELTON
- **STATE:** CT
- **ZIP:** 06484

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ENERGIZER HOLDINGS INC
- **DATE OF NAME CHANGE:** 19991013

**As filed with the Securities and Exchange Commission on February 24, 2023**

**Registration No. 333-**

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM S-8** 

**REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933** 

**EDGEWELL PERSONAL CARE COMPANY** 

**(Exact Name Of Registrant As Specified In Its Charter)** 

______________________________________________________________________________________________________

---

| | |
|:---|:---|
| **Missouri** | **43-1863181** |
| **(State or other jurisdiction of<br>incorporation or organization)** | **(I.R.S. Employer<br>Identification No.)** |
| **6 Research Drive,<br>Shelton, CT** | **06484** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**EDGEWELL PERSONAL CARE COMPANY**

**2ND AMENDED AND RESTATED 2018 STOCK INCENTIVE PLAN** 

**(Full Title of the Plan)**

**Daniel J. Sullivan**

**Chief Financial Officer**

**EDGEWELL PERSONAL CARE COMPANY**

**6 Research Drive**

**Shelton, Connecticut 06484** 

**(203) 944-5500**

**(Name, address, and telephone number, including area code, of agent for service)** 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | ☐ |
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ |
| | | Emerging growth company | ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. □

------

**EXPLANATORY NOTE** 

**Registration of Additional Securities**

<u>2</u><sup>nd</sup> <u>Amended and Restated 2018 Stock Incentive Plan</u>

On November 3rd, 2022, Edgewell Personal Care Company's Board of Directors adopted the 2<sup>nd</sup> Amended and Restated 2018 Stock Incentive Plan (the "2<sup>nd</sup> A&R 2018 Plan."). On February 3, 2023, the shareholders of the Company approved the adoption of the 2<sup>nd</sup> A&R 2018 Plan. The 2<sup>nd</sup> A&R 2018 Plan amends and restates our Company's Amended and Restated 2018 Stock Incentive Plan (the "A&R 2018 Plan") and includes an additional 3,000,000 shares of Common Stock, $0.01 par value per share (the "Common Stock"), of the Company available for grant and issuance, plus the number of remaining shares of Common Stock not issued or subject to outstanding grants under the A&R 2018 Plan, plus any shares of Common Stock that are subject to awards granted under the A&R 2018 Plan that expire, are forfeited or canceled or terminate for any other reason after February 6, 2020 without the issuance of shares. We are filing this Registration Statement on Form S-8 to register an additional 3,000,000 shares of our Common Stock under the 2<sup>nd</sup> A&R 2018 Plan as a result of the increase as adopted by our Board of Directors and approved by our shareholders.

In accordance with Instruction E of Form S-8, this Registration Statement on Form S-8 incorporates by reference the contents of the Registration Statement on Form S-8, Registration No. 333-236414, relating to shares of our Common Stock reserved for issuance under the A&R 2018 Plan.

Unless the context otherwise requires, references made herein to "Edgewell," "the Company," "Registrant," "we," "us," "our" and "ours" refer to Edgewell Personal Care Company and its consolidated subsidiaries.

------

**Part I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS** 

The Registrant is not filing or including in this Registration Statement the information called for in Part I of Form S-8 (by incorporation, by reference or otherwise) in accordance with the rules and regulations of the Securities and Exchange Commission ("SEC"). The documents containing the information specified in Part I of this Registration Statement will be sent or given to eligible employees as specified by Rule 428(b)(1) promulgated under the Securities Act of 1933, as amended (the "Securities Act"). Such documents are not being filed with the SEC either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 promulgated under the Securities Act. These documents and the documents incorporated by reference into this Registration Statement pursuant to Item 3 of Part II of Form S-8, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

**Part II** 

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT** 

**Item 3. Incorporation of Documents by Reference.**

The following documents listed in (a) through (d) below, which are on file with the SEC, are incorporated herein by reference (except for the portions of the Company's Current Reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 thereof or otherwise not filed with the SEC which are deemed not to be incorporated by reference into this Registration Statement):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.The Company's Annual Report on <u>[Form 10-K](https://www.sec.gov/ix?doc=/Archives/edgar/data/1096752/000109675222000033/epc-20220930.htm)</u> for the year ended September 30, 2022, filed with the SEC on November 16, 2022;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.The Company's Quarterly Report on <u>[Form 10-Q](https://www.sec.gov/ix?doc=/Archives/edgar/data/1096752/000109675223000004/epc-20221231.htm)</u> for the quarter ended December 31, 2022, filed with the SEC on February 8, 2023;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.All other reports filed by the Registrant with the SEC pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), since the end of the fiscal year covered by the Registrant's Annual Report referred to in (1) above; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.The description of the Company's Common Stock contained in its Registration Statement on <u>[Amendment No. 3 to Form 10, dated March 16, 2000](https://www.sec.gov/Archives/edgar/data/1096752/000109675200000011/0001096752-00-000011.txt)</u>, including any amendments or reports filed for the purpose of updating such description.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. All documents filed by the Company with the SEC pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date hereof and prior to the filing of a post-effective amendment hereto which indicates that all securities offered hereunder have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents except that the portion of any Current Report on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 thereof shall not be incorporated by reference herein.

For purposes of this Registration Statement, any statement contained in a document incorporated or deemed to be incorporated herein by reference shall be deemed to be modified or superseded to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated herein by reference modifies or supersedes such statement in such document. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 4. Description of Securities.**

Not applicable.

**Item 5. Interests of Named Experts and Counsel.**

The validity of the shares of Common Stock offered hereby has been passed upon by LaTanya Langley, Chief Legal Officer of Edgewell Personal Care Company. Ms. Langley is eligible to participate in the 2nd A&R 2018 Plan, and she currently beneficially owns 565 shares of Common Stock and has been awarded options to purchase 13,573 shares of Common Stock, restricted stock equivalent units convertible into 16,193 shares of Common Stock and performance restricted stock equivalents convertible into 12,597 shares of Common Stock, under the terms of the A&R 2018 Plan.

------

**Item 6. Indemnification of Directors and Officers.**

We are a Missouri corporation. Section 351.355 of the Missouri General and Business Corporation Law (the "GBCL") provides that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, other than an action by or in the right of the corporation, by reason of the fact that he or she is or was a director, officer, employee or agent of the corporation, against expenses, including attorneys' fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful. In the case of a derivative action or suit by or in the right of the corporation, no person shall be indemnified as to any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his or her duty to the corporation, unless and only to the extent that the court in which the action or suit was brought determines upon application that, despite the adjudication of liability and in view of all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for expenses which the court shall deem proper. Our articles of incorporation generally provide that we shall indemnify each person (other than a party plaintiff suing on his or her own behalf or in a derivative action in our right) who at any time is serving or has served as a director, officer or employee of the corporation against any claim, liability or expense incurred as a result of such service, to the maximum extent permitted by law. We will also indemnify any such person against expenses (including, without limitation, costs of investigation and attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him or her in connection with such action, suit or proceeding.

Section 351.355(3) of the GBCL provides that, except as otherwise provided in the corporation's articles of incorporation or the bylaws, to the extent a director, officer, employee or agent of the corporation has been successful on the merits or otherwise in the defense of any action, suit or proceeding or any claim, issue or matter therein, he or she shall be indemnified against expenses, including attorneys' fees, actually and reasonably incurred by him or her in connection with the action, suit or proceeding. Our articles of incorporation provide that such indemnification shall be mandatory.

Section 351.355(5) of the GBCL provides that expenses incurred in defending any civil, criminal, administrative or investigative action, suit, or proceeding may be paid by the corporation in advance of the final disposition of the action, suit, or proceeding as authorized by the board of directors in the specific case upon receipt of an undertaking by or on behalf of the director, officer, employee or agent to repay such amount unless it shall ultimately be determined that he or she is entitled to be indemnified by the corporation as authorized in that section.

Our articles of incorporation and restated bylaws provide that the liability of our directors, officers and employees to us, its shareholders or otherwise is limited to the fullest extent permitted by the GBCL. Consequently, should the GBCL or any other applicable law be amended or adopted hereafter so as to permit the elimination or limitation of such liability, the liability of the directors, officers, or employees of the corporation shall be so eliminated or limited without the need for amendment to our articles of incorporation or further action on the part of the shareholders of the corporation.

As permitted by Section 351.355(7) of the GBCL and as authorized by our articles of incorporation, we have entered into indemnification contracts with our directors. Pursuant to those agreements, we have agreed to indemnify the directors to the full extent authorized or permitted by the GBCL. The agreements also provide for the advancement of expenses of defending any civil or criminal action, claim, suit or proceeding against the director and for repayment of such expenses by the director if it is ultimately judicially determined that the director is not entitled to such indemnification.

As permitted by Section 551.355(8) of the GBCL and as authorized by our articles of incorporation, we have purchased directors' and officers' insurance which protects each director and officer from liability for actions taken in their capacity as directors or officers. This insurance may provide broader coverage for such individuals than may be required by the provisions of our restated articles of incorporation.

The foregoing represents a summary of the general effect of the indemnification provisions of the GBCL, our articles of incorporation and such agreements and insurance. Additional information regarding indemnification of directors and officers can be found in Section 351.355 of the GBCL, our articles of incorporation and any pertinent agreements.

**Item 7. Exemption from Registration Claimed.**

Not applicable.

------

**Item 8. Exhibits.[1]**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 4.1 | <u>[Amended and Restated Articles of Incorporation of the Company (which is incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2013, filed on January 30, 2014).](https://www.sec.gov/Archives/edgar/data/1096752/000109675214000021/enr10q123113ex31.htm)</u> |
| 4.2 | <u>[Articles of Merger effective June 30, 2015 (which is incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on July 1, 2015).](https://www.sec.gov/Archives/edgar/data/1096752/000119312515242462/d40769dex31.htm)</u> |
| 4.3 | <u>[Amended and Restated Bylaws of the Company effective November 5, 2020 (which is incorporated by reference to Exhibit 3.3 to the Company's Annual Report on Form 10-K for the year ended September 30, 2021, filed on November 19, 2021).](https://www.sec.gov/Archives/edgar/data/1096752/000109675221000032/epc10-k93021ex33.htm)</u> |
| 4.4 | <u>[Edgewell Personal Care Company 2](https://www.sec.gov/Archives/edgar/data/1096752/000114036122046229/ny20005025x1_def14a.htm)</u><sup>nd</sup><u>[Amended and Restated 2018 Stock Incentive Plan, as amended and restated, effective February 3, 2023 (which is incorporated by reference to Exhibit A to the Company's Definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934 filed on December 20, 2022).](https://www.sec.gov/Archives/edgar/data/1096752/000114036122046229/ny20005025x1_def14a.htm)</u> |
| 5.1# | <u>[Opinion of LaTanya Langley, Chief Legal Officer of Edgewell Personal Care Company.](s-8legalopinion.htm)</u> |
| 23.1# | <u>[Consent of PricewaterhouseCoopers LLP.](s-8pwcconsent.htm)</u> |
| 23.2# | <u>[Consent of LaTanya Langley (included in Exhibit 5.1).](s-8legalopinion.htm)</u> |
| 24.1# | <u>[Power of Attorney (contained on the page following the signature page hereto).](#iff82ed0397b04d56ad182358055b050b_7)</u> |
| 107# | <u>[Filing fee table.](s-8filingfeetable.htm)</u> |

---

# Filed herewith.

**Item 9. Undertakings.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The undersigned Registrant hereby undertakes;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the "Calculation of Registration Fee" table in the effective registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement or any material change to such information in this Registration Statement.

Provided, however, that the undertakings set forth in paragraphs (a)(1)(i) and (a)(1)(ii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The undersigned Registrant hereby further undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act and, where applicable, each filing of the 2nd A&R 2018 Plan's annual report pursuant to Section 15(d) under the Exchange Act, that is incorporated by reference in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Shelton, State of Connecticut, on February 24, 2023.

EDGEWELL PERSONAL CARE COMPANY.

By: <u>/s/ Daniel J. Sullivan</u> 

Daniel J. Sullivan

Chief Financial Officer

------

**POWER OF ATTORNEY** 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Daniel J. Sullivan and LaTanya Langley, and any one or more of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and any additional registration statements pursuant to Rule 462(b) of the Securities Act, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the SEC, and hereby grants to such attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the date indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| /s/ Rod R. Little | Chief Executive Officer and Director (Principal Executive Officer | February 24, 2023 |
| Rod R. Little | Chief Executive Officer and Director (Principal Executive Officer | February 24, 2023 |
| /s/ Daniel J. Sullivan | Chief Financial Officer (Principal Financial Officer | February 24, 2023 |
| Daniel J. Sullivan | Chief Financial Officer (Principal Financial Officer | February 24, 2023 |
| /s/ Robert Schmidt | Chief Accounting Officer (Principal Accounting Officer | February 24, 2023 |
| Robert Schmidt | Chief Accounting Officer (Principal Accounting Officer | February 24, 2023 |
| /s/ Robert W. Black | Director | February 24, 2023 |
| Robert W. Black |  | February 24, 2023 |
| /s/ George R. Corbin | Director | February 24, 2023 |
| George R. Corbin |  | February 24, 2023 |
| /s/ Carla C. Hendra | Director | February 24, 2023 |
| Carla C. Hendra |  | February 24, 2023 |
| /s/ John C. Hunter, III | Non-Executive Chairman of the Board | February 24, 2023 |
| John C. Hunter, III |  | February 24, 2023 |
| /s/ James C. Johnson | Director | February 24, 2023 |
| James C. Johnson |  | February 24, 2023 |
| /s/ Joseph D. O'Leary | Director | February 24, 2023 |
| Joseph D. O'Leary |  | February 24, 2023 |
| /s/ Rakesh Sachdev | Director | February 24, 2023 |
| Rakesh Sachdev |  | February 24, 2023 |
| /s/ Swan Sit | Director | February 24, 2023 |
| Swan Sit |  | February 24, 2023 |
|  |  | February 24, 2023 |
| /s/ Gary Waring | Director | February 24, 2023 |
| Gary Waring |  | February 24, 2023 |

---

## Ex-Filing

**Exhibit 107**

**Calculation of Filing Fee Tables**

<u>Form S-8</u>

(Form Type)

<u>Edgewell Personal Care Company</u>

(Exact name of Registrant as Specified in its Charter)

**CALCULATION OF REGISTRATION FEE**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Security <br>Type** | **Title of Securities To be Registered** | **Fee Calculation Rule**<sup>(1)</sup> | **Amount** <br>**to be**<br> **Registered**<sup>(2)(</sup><sup>3)</sup> | **Proposed Maximum Offering Price Per Share**<sup>(1)</sup> | **Maximum Aggregate Offering Price**<sup>(1)</sup> | **Fee Rate** | **Amount of**<br>**Registration**<br>**Fee**<sup>(1) (3)</sup> |
| Equity | Common Stock,<br>$0.01 par value per share | Other | 3000000 | $44.05 | $13216500 | $110.20 per $1,000,000 (0.0001102) | $14564.58 |

---

(1) Calculated pursuant to Rules 457(c) and 457(h) under the Securities Act solely for the purpose of calculating the amount of the registration fee, on the basis of the average of the high and low prices of the shares of Common Stock of Edgewell Personal Care Company reported on the New York Stock Exchange on February 21, 2023.

(2) Pursuant to Rule 416(a) under the Securities Act, this Registration Statement also covers additional securities that may be offered as a result of stock splits, stock dividends or similar transactions.

(3) Calculated pursuant to General Instruction E on Form S-8.

## Exhibit 5.1

**Exhibit 5.1**

February 24, 2023

Edgewell Personal Care Company

6 Research Drive

Shelton, CT 06484

**Re: Registration Statement on Form S-8**

Ladies and Gentlemen:

I have acted as counsel to Edgewell Personal Care Company, a Missouri corporation (the "***Company***"), in connection with the preparation of a Registration Statement on Form S-8 ("***Form S-8***") under the Securities Act of 1933, as amended, which the Company is filing with the Securities and Exchange Commission with respect to certain shares (the "***Shares***") of common stock of the Company, par value $0.01 per share, that may be issued under the Edgewell Personal Care Company 2nd Amended and Restated 2018 Stock Incentive Plan (the "**2nd A&R 2018 Plan**"). The aggregate maximum number of such Shares being 3,000,000, subject to any additional securities that may be offered as a result of stock splits, stock dividends or similar transactions pursuant to the terms of the 2<sup>nd</sup> A&R 2018 Plan.

The opinions expressed herein are limited exclusively to the applicable provisions of the Missouri General and Business Corporation Law as currently in effect, and I express no opinion as to the effect of the laws of any other jurisdiction.

I have examined the Registration Statement on Form S-8 and such documents and records of the Company as I have deemed necessary for the purpose of this opinion. In giving this opinion, I am assuming the authenticity of all instruments presented to me as originals, the conformity with originals of all instruments presented to me as copies, the authenticity of the originals of such copies and the genuineness of all signatures. As to various facts material to such opinion, I have, to the extent relevant facts were not independently established by me, relied on certificates of public officials and certificates and oaths and declarations of officers or other representatives of the Company.

Based upon and subject to the foregoing, I am of the opinion that any original issuance Shares that may be issued pursuant to the 2nd A&R 2018 Plan, upon the due execution by the Company of any certificates representing the Shares, the registration by its registrar of such Shares and the issuance thereof by the Company in accordance with the terms of the 2nd A&R 2018 Plan, and the receipt of consideration therefor in accordance with the terms of the 2nd A&R 2018 Plan, will be duly authorized, validly issued, fully paid and nonassessable.

I hereby consent to the filing of this opinion as an exhibit to the Registration Statement on Form S-8. I further consent to the filing of copies of this opinion with agencies of such states and other jurisdictions as the Company deems necessary in the course of complying with the laws of the states and jurisdictions as it deems necessary regarding the sale and issuance of the Shares in accordance with the 2nd A&R 2018 Plan.

Very truly yours,

<u>/s/ LaTanya Langley</u> 

LaTanya Langley

Chief Legal Officer

## Exhibit 23.1

**Exhibit 23.1**

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Edgewell Personal Care Company of our report dated November 16, 2022 relating to the financial statements, financial statement schedules and the effectiveness of internal control over financial reporting, which appears in Edgewell Personal Care Company 's Annual Report on Form 10-K for the year ended September 30, 2022.

/s/ PricewaterhouseCoopers LLP

St. Louis, Missouri

February 24, 2023

<br>